396059004: Fluocinolone acetonide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Fluorinated corticosteroid\Fluocinolone acetonide (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluocinolone acetonide (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Steroid hormone\Fluorinated corticosteroid\Fluocinolone acetonide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\...

\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluocinolone acetonide (substance)

\Steroid hormone\Fluorinated corticosteroid\Fluocinolone acetonide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469999018 Fluocinolone acetonide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489684010 Fluocinolone acetonide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

812401000172117 fluocinolone acétonide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fluocinolone acetonide (substance)	Is a	Fluocinolone (substance)	false	Inferred relationship	Some
Fluocinolone acetonide (substance)	Is a	Synthetic glucocorticoid, fluorinated	false	Inferred relationship	Some
Fluocinolone acetonide (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Fluocinolone (substance)	true	Inferred relationship	Some
Fluocinolone acetonide (substance)	Is a	Fluorinated corticosteroid	true	Inferred relationship	Some
Fluocinolone acetonide (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fluocinolone acetonide topical preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide 250 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 25 microgram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide 250 microgram/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous shampoo (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing fluocinolone acetonide and hydroquinone and tretinoin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide 100 microgram/mL cutaneous oil	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Dermasmoothe/fs	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone acetonide 0.01% ear drops oil	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Fluocinolone 0.59mg ocular implant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g cutaneous gel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g cutaneous gel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 25 microgram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 25 microgram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Fluocinolone acetonide (substance)	Inferred relationship	Some	2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Fluocinolone acetonide (substance)	Inferred relationship	Some	2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 100 microgram/mL cutaneous oil	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 100 microgram/mL cutaneous oil	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	3
Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	3
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous shampoo (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous shampoo (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and fluocinolone acetonide 250 microgram/1 milliliter conventional release solution for ear drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	2
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and fluocinolone acetonide 250 microgram/1 milliliter conventional release solution for ear drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	2
Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	2
Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fluocinolone acetonide (substance)	Inferred relationship	Some	2

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469999018	Fluocinolone acetonide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489684010	Fluocinolone acetonide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
812401000172117	fluocinolone acétonide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module